Search Tag: lung cancer
Affidea Partners With Aidence In Lung Cancer Diagnosis And Screening With The Use Of AI
2019 04 Dec
Affidea and Aidence announce a strategic partnership to streamline and improve the clinical performance of lung diagnosis and screening to drive the earlier detection and treatment in the case of lung cancer. As the leading European provider of advanced diagnostic imaging services, Affidea is starting the collaboration with Aidence, a medical... Read more
Mayo Clinic Diagnostic Imaging Update and Self-Assessment 2019
2019 15 Jul
Find MayoClinic Radiology on Social Media Read more
The winner of the Value-Based Health Care Prize 2019 is GLA:D!
2019 03 Jun
On Thursday April 18, The Value-Based Health Care Prize was awarded to Good Life with Osteoarthritis in Denmark (GLA:D®) . Besides the prize, four excellence awards and the inspirational award were awarded to five inspiring initiatives. This year, a total of thirteen initiatives were nominated by the international expert jury to compete for... Read more
Thermal ablation: safe and effective for treating early-stage lung cancer
2018 19 Sep
New Yale-led research demonstrates that thermal ablation is safe and effective in the treatment of early-stage lung cancer. Since ablation uses no radiation, thus reducing medical cost, this approach may be a viable option for patients who cannot undergo lung cancer surgery because of age or health status, according to the study published in the... Read more
USA: Lung cancer screening low despite USPSTF recommendations
2018 22 May
New research highlights the need for more efforts to promote lung cancer screening, as only 1.9 percent of more than 7 million current and former heavy smokers were screened for lung cancer in 2016. The study is the first to examine lung cancer screening rates since the United States Preventive Services Task Force (USPSTF) issued screening recommendations... Read more
Low-dose CT screening important in reducing lung cancer deaths
2018 27 Feb
About 1.6 million people die of lung cancer each year, making it the leading cause of cancer-related deaths in the world. The poor outcomes of treatment in lung cancer resulting from the fact that most cases are diagnosed in the advanced stage of the disease justify the implementation of an optimal lung cancer prevention in the form of smoking cessation... Read more
The answer to noninvasive biomarker development in lung cancer
2017 28 Nov
During an overcrowded exhilarating session on Monday 27th November at the RSNA 2017 Congress in Chicago, Dr. Hugo Aerts, from Harvard University in Cambridge, explained to delegates that artificial intelligence (AI) is indeed playing a pivotal role in the development of new imaging biomarkers for lung cancer. A key topic of interest... Read more
Lung cancer: differentiating metastatic from nonmetastatic lymph nodes
2017 26 Sep
New research demonstrates that dynamic first-pass contrast-enhanced (CE) perfusion area-detector CT (ADCT) is as useful as FDG PET/CT for the differentiation of metastatic from nonmetastatic lymph nodes and assessment of N stage in patients with non-small cell lung carcinoma (NSCLC). In addition, researchers found that using mathematic methods and... Read more
Acceptability of whole-body MRI for staging colorectal and lung cancer
2017 19 Sep
A new study sought to describe patient experience and acceptability of whole-body magnetic resonance imaging (WB-MRI) as a potential replacement for the modalities currently used for staging lung and colorectal cancer. The findings, published in the journal BMJ Open, confirm that WB-MRI can be a challenging experience and that staff support is important... Read more